Quantcast

Latest Non-steroidal anti-inflammatory drugs Stories

a865bf2f0eb46a0ac3a36b9043d1fc541
2009-12-15 14:10:00

Combining celebrex with low-dose aspirin may reduce protection from heart attack and stroke, study suggests Millions of Americans take Celebrex for arthritis or other pain. Many, if they are middle-aged or older, also take a low-dose aspirin tablet daily to reduce the risk of heart attack and stroke. Yet they may be getting little protection, because Celebrex keeps the aspirin from doing its job effectively, a new study suggests. In laboratory studies, University of Michigan researchers found...

1d878ed06e7032cba4ab1d9e4d2ce493
2009-12-10 07:38:06

A second veterinary pain drug used to treat cattle could be deadly to endangered vultures that feed on the carcasses of livestock, according to a study released Wednesday. The death toll of the slender-billed and oriental white-backed vultures has reached the millions in South Asia, mostly in India, after consuming the carcasses of sick cattle that had been treated with anti-inflammatory painkiller diclofenac, reported the Associated Press. Researchers writing in the Royal Society journal...

2009-12-09 08:00:00

Nashville, Tenn., Dec. 9 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced that it has entered into an exclusive agreement with DB Pharm Korea Co. Ltd., a Korean-based pharmaceutical company, for the commercialization of Caldolor® (ibuprofen) Injection in South Korea. Designed to treat pain and fever in the hospital setting, Caldolor was approved by the U.S. Food and Drug Administration and launched by Cumberland in the United States...

2009-12-03 10:28:00

NASHVILLE, Tenn., Dec. 3 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) announced today that data from a recent clinical trial for Caldolor® (ibuprofen) Injection, an intravenous treatment for pain and fever, will be presented at the 44th American Society of Health-System Pharmacists (ASHP) Midyear Clinical Meeting in Las Vegas, Nevada, in December. The new data will be displayed in a poster presentation on Monday, December 7, from 2:30 to 5:00...

6cf3321b758f96daabe3563b1f2d8dff
2009-12-02 08:20:50

Mizzou scientists discover aspirin and Tylenol block enzymes that could inhibit vaccines With flu season in full swing and the threat of H1N1 looming, demand for vaccines is at an all-time high. Although those vaccines are expected to be effective, University of Missouri researchers have found further evidence that some over-the-counter drugs, such as aspirin and Tylenol, that inhibit certain enzymes could impact the effectiveness of vaccines. "If you're taking aspirin regularly, which many...

2009-12-01 13:37:02

Overall use of blood-thinning agents not improving despite more options Since 1999, stroke survivors have been advised to use aspirin, prescription antiplatelet agents, or prescription anticoagulants to help avoid another stroke. Many large surveys of the U.S. population have reported the use of aspirin for secondary prevention, but commonly combine people with stroke and coronary artery disease, and only rarely report the use of antithrombotic agents other than aspirin. In an article...

2009-11-23 16:57:24

Clinical trial data indicated an association between the anti-inflammatory medication rofecoxib and cardiovascular risk as early as December 2000, before the product was taken off the market in September 2004, according to a report in the November 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals. Rofecoxib was introduced to the market in May 1999 and quickly became a commercial success, with sales reaching $2 billion annually, according to background information in...

2009-11-23 08:00:00

NASHVILLE, Tenn., Nov. 23 /PRNewswire-FirstCall/ -- Cumberland Pharmaceuticals Inc. (Nasdaq: CPIX) today announced positive new top-line results from a study evaluating the safety and efficacy of Caldolor (ibuprofen) Injection in treating fever in hospitalized burn patients. Statistical significance was achieved for the primary endpoint of reducing fever in burn patients over the first 24 hours of treatment. The study evaluated 61 adult burn patients with second or third degree burns...

2009-11-18 14:40:39

Over 300 million patients use non-steroidal anti-inflammatory drugs (NSAIDs) in the world to treat pain, arthritis, fever and other diseases. Nearly 30% of the users suffer from gastric lesions and bleeding. To mitigate NSAIDs' adverse effects on the stomach, misoprostol, a non-selective prostaglandin E1 (PGE1) analogue, has been prescribed as the first choice for prevention of NSAID-induced injuries, but often induces severe adverse effects. There remain unmet medical needs for drugs with...

2009-11-12 11:47:00

NEW YORK, Nov. 12 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue. Diclofenac sodium (CAS 15307-79-6) Market Research Report 2009 http://www.reportlinker.com/p0163683/Diclofenac-sodium-(CAS-15307-79-6)-Market-Research-Report-2009.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=prnewswire The study 'Diclofenac sodium (CAS 15307-79-6) Market Research Report 2009' presents an overview of the Diclofenac sodium market...


Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.